CORZ Stock Up 52% after 6-Day Win Streak

CORZ: Core Scientific logo
CORZ
Core Scientific

Core Scientific (CORZ) stock hit day 6 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 52% return. The company has gained about $2.8 Bil in value over the last 6 days, with its current market capitalization at about $5.4 Bil. The stock remains 22.8% above its value at the end of 2024. This compares with year-to-date returns of 5.4% for the S&P 500.

Comparing CORZ Stock Returns With The S&P 500

The following table summarizes the return for CORZ stock vs. the S&P 500 index over different periods, including the current streak:

Return Period CORZ S&P 500
1D 1.1% -0.1%
6D (Current Streak) 52.0% 2.9%
1M (21D) 62.0% 4.8%
3M (63D) 138.3% 10.4%
YTD 2025 22.8% 5.4%
2024 23.3%
2023 24.2%
2022 -19.4%

Gains and Losses Streaks: S&P 500 Constituents

There are currently 182 S&P constituents with 3 days or more of consecutive gains and 8 constituents with 3 days or more of consecutive losses.

Consecutive Days # of Gainers # of Losers
3D 65 4
4D 88 0
5D 3 2
6D 1 2
7D or more 25 0
Total >=3 D 182 8

 

Relevant Articles
  1. Is Qualcomm Stock A Bet On AI’s Future Or A Hostage To The Smartphone’s Present?
  2. The Quiet Contract Shift Before Western Digital Stock’s Loud Re-Rating
  3. Beyond the Quarter: What Could Power The Next Leg Of Broadcom Stock’s Climb
  4. Booking Stock Testing Price Floor – Buy Now?
  5. Ciena’s AI Story Is Soaring. Is Ubiquiti The Smarter Play?
  6. Flex’s AI Story Is Soaring. Is TE Connectivity The Wiser Bet?

Key Financials for Core Scientific (CORZ)

Last 2 Fiscal Years:

Metric FY2023 FY2024
Revenues $502.4 Mil $510.7 Mil
Operating Income $15.3 Mil $-12.2 Mil
Net Income $-246.5 Mil $-1.3 Bil

Last 2 Fiscal Quarters:

Metric 2024 FQ4 2025 FQ1
Revenues $94.9 Mil $79.5 Mil
Operating Income $-39.6 Mil $-42.6 Mil
Net Income $-265.5 Mil $580.7 Mil

While CORZ stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming the S&P 500 over the last 4-year period. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.